1 year return (CAGR)
35.20%
Fate Therapeutics Inc Exchange (NASDAQ, USD)
FATE
2.08
-0.06 (-2.61%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
0.08%
5 year return (CAGR)
-49.09%
10 year return (CAGR)
-2.14%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
246.23M
Price/Sales
37.93
Ent value
320.47M
Price/Book
1.60
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-11.42%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.10 |
| Daily high | 2.14 |
| Daily low | 2.04 |
| Daily Volume | 1.46M |
| All-time high | 117.40 |
| 1y analyst estimate | 5.74 |
| Beta | 2.55 |
| EPS (TTM) | -1.05 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 2 Mar 2026 |
Downside potential
Loading...
Downside potential data
| FATE | S&P500 | |
| Current price drop from All-time high | -98.23% | -3.00% |
| Highest price drop | -99.42% | -56.47% |
| Date of highest drop | 3 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -59.68% | -10.65% |
| Avg time to new high | 40 days | 12 days |
| Max time to new high | 1452 days | 1805 days |
News
